Results 111 to 120 of about 27,178 (263)
Immunotherapy in allergic conjunctivitis.
Indian journal of ophthalmology, 1992 Eighty patients with allergic conjunctivitis were treated with immunotherapy employing specific allergens. Sixty-two percent of these showed beneficial response. In cases of vernal conjunctivitis needing topical steroid preparations frequently for control of symptoms, immunotherapy is worth attempting to cause remission of symptoms.
Prakash O, Murthy K
openaire +2 more sources
Health Science Reports, Volume 8, Issue 7, July 2025.ABSTRACT Background and Aims Registries are powerful tools for data management. Designing a minimum data set as the first step in registry development helps collect relevant and efficient data. The aim of this study was to develop a minimum data set for the primary immunodeficiency registry system.
Saman Mohammadpour +5 more
wiley +1 more source
Comparative study of the efficacy and safety of olopatadine eyedrops and sodium cromoglycate in clinical practice: a prospective study [PDF]
, 2016 Background: Allergic eye diseases are the commonest causes of ocular morbidity worldwide. To choose the best therapy in allergic conjunctivitis, understanding of underlying mechanisms implicated in triggering the allergy is very important.
K., Scandashree +2 more
core +2 more sources
French guidelines for the management of atopic dermatitis
Journal of the European Academy of Dermatology and Venereology, EarlyView.
Nina Sigg +16 more
wiley +1 more source
Patients With IgA Vasculitis and Kawasaki Disease Show Dysregulated Interferon Signature
International Journal of Rheumatic Diseases, Volume 28, Issue 7, July 2025.ABSTRACT Objective IgA vasculitis (IgAV) and Kawasaki disease (KD) are the most common forms of childhood vasculitis. Although various factors such as viral infections, genetic factors, and environmental factors are involved in the development of both diseases, their pathogenesis remains unclear.
Sevki Erdem Varol +9 more
wiley +1 more source
Risks for comorbidity in children with atopic disorders: an observational study in Dutch general practices [PDF]
, 2017 OBJECTIVE: This study aimed to investigate both atopic and non-atopic comorbid symptoms and diseases in children with physician-diagnosed atopic disorders (atopic eczema, asthma and allergic rhinitis).METHODS: All children aged 0-18 years listed in a ...
Bindels, P.J.E. (Patrick) +4 more
core +2 more sources
Clinical &Experimental Ophthalmology, Volume 53, Issue 5, Page 457-469, July 2025.ABSTRACT Background In the last two decades, over 250 000 refugees and asylum seekers have arrived in Australia, many of whom experience significant health problems. Information about their eye health is scarce, particularly for those detained offshore. This is the first study to explore the eye health and services available to this population, helping
Marcel M. Nejatian +3 more
wiley +1 more source
Clinical &Experimental Ophthalmology, Volume 53, Issue 5, Page 470-492, July 2025.ABSTRACT Background To identify evidence on the use of topical CsA for ocular surface diseases (OSD). Methods A literature search was conducted following the preferred reporting items for systematic reviews and meta‐analyses (PRISMA) through June 2023 via Cochrane Central Registries, Clinical Trials Registry, Grey literature and citation searching ...
Ngozi C. Chidi‐Egboka +10 more
wiley +1 more source
Tear IgE concentrations in allergic conjunctivitis [PDF]
, 1998 Keiko Nomura, Etsuko Takamura
openalex +1 more source
Clinical and Translational Science, Volume 18, Issue 7, July 2025.Since its authorisation in 2020, Dexamethasone 1 mg/mL + Levofloxacin 5 mg/mL Eye Drops, Solution has been administered to approximately 4 million patients worldwide for prevention and treatment of inflammation and prevention of infection associated with cataract surgery in adults.
Giorgio Ciprandi +5 more
wiley +1 more source